Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of platelets in regulating activated coagulation factor XI activity. | Am J Physiol Cell Physiol | 2021 | 33471623 | PubTator, text mining | PubMed |
| Neutrophils can promote clotting via FXI and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro. | Sci Rep | 2021 | 33462294 | PubTator, text mining | PubMed |
| Competition-Based Cell Assay Employing Soluble T Cell Receptors to Assess MHC Class II Antigen Processing and Presentation. | AAPS J | 2021 | 33459871 | PubTator, text mining | PubMed |
| Development of Coronavirus Treatments Using Neutralizing Antibodies. | Microorganisms | 2021 | 33451069 | PubTator, text mining | PubMed |
| ONO-7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first-in-human study. | Br J Clin Pharmacol | 2021 | 33450079 | PubTator, text mining | PubMed |
| Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study. | Am J Transplant | 2021 | 33445220 | PubTator, text mining | PubMed |
| Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis. | Heliyon | 2021 | 33437888 | PubTator, text mining | PubMed |
| Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge-A Systematic Literature Review. | J Clin Med | 2021 | 33435610 | PubTator, text mining | PubMed |
| Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients. | Hum Genomics | 2021 | 33431054 | PubTator, text mining | PubMed |
| Plasma contact factors as novel biomarkers for diagnosing Alzheimer's disease. | Biomark Res | 2021 | 33422144 | PubTator, text mining | PubMed |
| Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice. | J Thromb Haemost | 2021 | 33421301 | PubTator, text mining | PubMed |
| Essential role of a carboxyl-terminal α-helix motif in the secretion of coagulation factor XI. | J Thromb Haemost | 2021 | 33421272 | PubTator, text mining | PubMed |
| Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes. | Genes (Basel) | 2021 | 33418956 | PubTator, text mining | PubMed |
| Coronavirus Disease 2019-Associated Coagulopathy. | Mayo Clin Proc | 2021 | 33413819 | PubTator, text mining | PubMed |
| An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody. | PLoS One | 2021 | 33412571 | PubTator, text mining | PubMed |
| Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage. | Neurocrit Care | 2021 | 33403588 | PubTator, text mining | PubMed |
| Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI. | Proc Natl Acad Sci U S A | 2021 | 33397811 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Is PAD a Hypercoagulable Disorder? | Arterioscler Thromb Vasc Biol | 2021 | 33356366 | PubTator, text mining | PubMed |
| Enabling accurate measurement of activated factor XI (FXIa) in therapeutic immunoglobulin products. | Vox Sang | 2021 | 33277936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=56